The Union health ministry has invited applications for the post of Drugs Controller General of India (DCGI) to head the Central Drugs Standard Control Organisation (CDSCO). The move follows an April 2026…
Eisai has launched Leqembi, or lecanemab, in India for patients with mild cognitive impairment and mild dementia caused by early Alzheimer’s disease, after receiving marketing authorisation from the Central Drugs Standard Control…
The Centre told Parliament that India's drug regulator CDSCO does not use AI for regulatory approvals, relying instead on scientific and technical review. Separately, CDSCO issued guidance for AI-enabled medical device software,…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.